Stocksigma LogoStocksigma Logo

RPG Life Sciences Completes ₹243.33 Crore Stake Sale in Subsidiary RPGAP

RPG Life Sciences announced that its subsidiary, RPG Active Pharma Limited (RPGAP), allotted securities to India Life Sciences Fund IV Domestic and

RPG Life Sciences Completes ₹243.33 Crore Stake Sale in Subsidiary RPGAP

RPG Life Sciences Ltd · Others (Uncategorized) · 10 Sept 2026, 4:20 am

RPG Life Sciences Completes ₹243.33 Crore Stake Sale in Subsidiary RPGAP RPG Life Sciences announced that its subsidiary, RPG Active Pharma Limited (RPGAP), allotted securities to India Life Sciences Fund IV Domestic and Vistaject Fund on 9th Sep'26. The transaction raised a total consideration of INR 243.33 crores, representing a 40% equity stake in RPGAP pursuant to the investment agreement dated 29th Jul'26. Following this allotment, RPGAP continues to operate as a subsidiary of RPG Life Sciences.

Original exchange filing (PDF)

More announcements from RPG Life Sciences Ltd

All RPG Life Sciences Ltd announcements